Dyadic International (DYAI) Competitors $0.95 -0.05 (-5.00%) As of 02:20 PM Eastern Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock DYAI vs. NKTX, NMRA, THTX, CTNM, KYTX, EXOZ, ATOS, IVVD, BHST, and PROCShould you be buying Dyadic International stock or one of its competitors? The main competitors of Dyadic International include Nkarta (NKTX), Neumora Therapeutics (NMRA), Theratechnologies (THTX), Contineum Therapeutics (CTNM), Kyverna Therapeutics (KYTX), Exozymes (EXOZ), Atossa Therapeutics (ATOS), Invivyd (IVVD), BioHarvest Sciences (BHST), and Procaps Group (PROC). These companies are all part of the "pharmaceutical products" industry. Dyadic International vs. Its Competitors Nkarta Neumora Therapeutics Theratechnologies Contineum Therapeutics Kyverna Therapeutics Exozymes Atossa Therapeutics Invivyd BioHarvest Sciences Procaps Group Dyadic International (NASDAQ:DYAI) and Nkarta (NASDAQ:NKTX) are both small-cap medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their community ranking, valuation, profitability, earnings, risk, analyst recommendations, institutional ownership, media sentiment and dividends. Is DYAI or NKTX more profitable? Nkarta has a net margin of 0.00% compared to Dyadic International's net margin of -188.09%. Nkarta's return on equity of -27.13% beat Dyadic International's return on equity.Company Net Margins Return on Equity Return on Assets Dyadic International-188.09% -149.16% -59.81% Nkarta N/A -27.13%-21.67% Do analysts prefer DYAI or NKTX? Dyadic International currently has a consensus price target of $6.00, suggesting a potential upside of 531.58%. Nkarta has a consensus price target of $14.33, suggesting a potential upside of 640.74%. Given Nkarta's stronger consensus rating and higher probable upside, analysts plainly believe Nkarta is more favorable than Dyadic International.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Dyadic International 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00Nkarta 0 Sell rating(s) 1 Hold rating(s) 5 Buy rating(s) 2 Strong Buy rating(s) 3.13 Which has stronger earnings & valuation, DYAI or NKTX? Dyadic International has higher revenue and earnings than Nkarta. Dyadic International is trading at a lower price-to-earnings ratio than Nkarta, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioDyadic International$3.34M8.55-$6.80M-$0.20-4.75NkartaN/AN/A-$117.50M-$1.51-1.28 Does the MarketBeat Community favor DYAI or NKTX? Dyadic International received 95 more outperform votes than Nkarta when rated by MarketBeat users. However, 76.74% of users gave Nkarta an outperform vote while only 64.40% of users gave Dyadic International an outperform vote. CompanyUnderperformOutperformDyadic InternationalOutperform Votes16164.40% Underperform Votes8935.60% NkartaOutperform Votes6676.74% Underperform Votes2023.26% Do insiders & institutionals have more ownership in DYAI or NKTX? 28.0% of Dyadic International shares are held by institutional investors. Comparatively, 80.5% of Nkarta shares are held by institutional investors. 29.5% of Dyadic International shares are held by insiders. Comparatively, 8.7% of Nkarta shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth. Which has more risk & volatility, DYAI or NKTX? Dyadic International has a beta of 0.92, suggesting that its stock price is 8% less volatile than the S&P 500. Comparatively, Nkarta has a beta of 0.72, suggesting that its stock price is 28% less volatile than the S&P 500. Does the media refer more to DYAI or NKTX? In the previous week, Nkarta had 8 more articles in the media than Dyadic International. MarketBeat recorded 9 mentions for Nkarta and 1 mentions for Dyadic International. Dyadic International's average media sentiment score of 1.89 beat Nkarta's score of 0.50 indicating that Dyadic International is being referred to more favorably in the media. Company Overall Sentiment Dyadic International Very Positive Nkarta Positive SummaryNkarta beats Dyadic International on 11 of the 18 factors compared between the two stocks. Get Dyadic International News Delivered to You Automatically Sign up to receive the latest news and ratings for DYAI and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding DYAI and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart DYAI vs. The Competition Export to ExcelMetricDyadic InternationalBiological Products IndustryMedical SectorNASDAQ ExchangeMarket Cap$28.59M$3.11B$5.60B$8.63BDividend YieldN/A1.57%5.28%4.18%P/E Ratio-4.1333.0627.2520.01Price / Sales8.55469.00412.71157.94Price / CashN/A168.6838.2534.64Price / Book4.753.437.124.70Net Income-$6.80M-$72.35M$3.24B$248.05M7 Day Performance-2.76%7.86%2.75%2.62%1 Month Performance-13.64%18.41%9.00%6.32%1 Year Performance-53.88%-16.84%31.41%13.78% Dyadic International Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)DYAIDyadic International2.2443 of 5 stars$0.95-5.0%$6.00+531.6%-55.2%$28.59M$3.34M-4.137Positive NewsGap DownNKTXNkarta3.6632 of 5 stars$1.73-0.6%$14.67+747.8%-69.2%$122.76MN/A-0.92140Positive NewsAnalyst ForecastNMRANeumora Therapeutics1.9752 of 5 stars$0.75+4.4%$9.29+1,141.6%-90.7%$120.97MN/A-0.40108THTXTheratechnologiesN/A$2.59-2.3%N/A+107.3%$119.09M$88.67M-25.90140Positive NewsCTNMContineum Therapeutics2.571 of 5 stars$4.43+21.0%$22.50+407.9%-71.3%$114.61M$50M-2.2531Positive NewsGap UpKYTXKyverna Therapeutics2.2135 of 5 stars$2.65+3.9%$18.50+598.1%-74.7%$114.53M$7.03M-0.7896Gap DownEXOZExozymesN/A$13.50+0.7%N/AN/A$112.97MN/A0.0029News CoverageGap DownATOSAtossa Therapeutics1.6401 of 5 stars$0.87+11.5%$7.13+722.0%-29.2%$111.97MN/A-3.948IVVDInvivyd3.8169 of 5 stars$0.93-0.5%$5.85+529.0%-46.4%$111.56M$36.69M-0.47100Positive NewsGap DownBHSTBioHarvest SciencesN/A$6.75+7.8%$13.67+102.5%N/A$110.87M$27.70M-5.40N/APositive NewsPROCProcaps GroupN/A$0.95-40.3%N/A-62.7%$107.18M$409.92M0.004,900Gap DownHigh Trading Volume Related Companies and Tools Related Companies Nkarta Alternatives Neumora Therapeutics Alternatives Theratechnologies Alternatives Contineum Therapeutics Alternatives Kyverna Therapeutics Alternatives Exozymes Alternatives Atossa Therapeutics Alternatives Invivyd Alternatives BioHarvest Sciences Alternatives Procaps Group Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:DYAI) was last updated on 6/12/2025 by MarketBeat.com Staff From Our PartnersTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | SponsoredTrump’s true trade war strategyThe media and financial pundits are all misreading Trump’s actions. They think Trump wants to make Canada t...Porter & Company | Sponsored[No Brainer Gold Play]: “Show me a better investment.”A Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredBig Changes Coming to Social Security?According to legendary investor Louis Navellier... This new Trump move could soon not only save Social Secu...InvestorPlace | SponsoredSHOCKING: Musk's Pentagon Secret Mission...It's about a harrowing message discovered on December 16, 2024: "美国军方暗杀名单" It's the reason President Tru...Behind the Markets | SponsoredAn AI run of epic proportions is only getting startedI just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredWhy Elon put $51 million into thisWhy Elon Musk Just Invested $51 Million Into Brand New “Miracle Metal” Developed by MIT ScientistsTrue Market Insiders | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Dyadic International, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Dyadic International With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy DYAI Stock Free DYAI Stock Alerts